In this issue:
Updates to NCCN breast cancer Clinical Practice Guidelines
Guideline for germline testing
The latest breast cancer screening guidelines
ACOG Clinical Practice Update
USPSTF recommendation statement
TGA registrations
PBS listings
Expansion of funded BRCA1/2 genetic testing
Affordable medications thanks to 60- day prescriptions
Upcoming PBAC agenda
Regulatory approvals across the globe
UK refuses to subside T-DXd for HER2-low metastatic disease
Levonorgestrel-releasing intrauterine systems linked to breast cancer risk
Phase 2 trial of TNBC vaccine about to commence
Survival benefit to perioperative pembrolizumab in TNBC
COVID-19 resources
Conferences & Workshops
Please login below to download this issue (PDF)